Xiangxue Pharmaceutical Co.,Ltd.
300147.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.62B
Close$
$-1.89
136.8% downside
Current Fair Value
136.8% downsideOvervalued by 136.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.62 Billion |
|---|---|
| Enterprise Value | $7.72 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.11 |
| Beta | 0.54 |
| Outstanding Shares | 658,718,543 |
Return
| Return on Equity | 227.02% |
|---|---|
| Return on Assets | -21.45% |
| Return on Invested Capital | 722.21% |
Valuation & Multiples
| P/E Ratio | -6.86 |
|---|---|
| PEG | -89.23 |
| Price to Sales | 2.57 |
| Price to Book Ratio | -5.14 |
| Enterprise Value to Revenue | 5.24 |
| Enterprise Value to EBIT | -7.63 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.55 |
| Debt to Equity | -6.81 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Xiangxue Pharmaceutical Co.,Ltd.
2,662 employees
CEO: Yonghui Wang Xiangxue Pharmaceutical Co., Ltd. is actively involved in the full pharmaceutical lifecycle within China, from scientific research and product development to sourcing, production, and market distribution. The company's product portfolio ...